The number of people with susceptibility test result for rifampicin in Colombia
Colombia: The number of people with susceptibility test result for rifampicin was 3,134 in 2021. ▲ Rising
Latest (2021)
3,134
Change on year
up 127.8%
World rank
39th
of 155 countries
All-time high
3,134
in 2021
All-time low
1,376
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Colombia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Colombia recorded 3,134 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
That represents a change of up 127.8% on the previous year and up 76.5% over five years.
Colombia ranks 39th of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Colombia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,776 | — |
| 2018 | 1,861 | +4.8% |
| 2019 | 2,080 | +11.8% |
| 2020 | 1,376 | -33.8% |
| 2021 | 3,134 | +127.8% |
Colombia compared with similar countries
- Colombia's 3,134 is above the median for upper middle income countries, which is 880, 3.6× the median. (46 countries reporting)
- Colombia's 3,134 is above the median for Latin America & Caribbean, which is 406.5, 7.7× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,906 | 1,776 | 2,080 | 3 |
| 2020s | 2,255 | 1,376 | 3,134 | 2 |
Countries ranked near Colombia
More health data for Colombia
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3468 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,505 deaths per 1,000 people (2090)
- Number of infants who die before age 1 698 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -0.3706 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0324 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3776 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Colombia?
- The number of people with susceptibility test result for rifampicin in Colombia was 3,134 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Colombia?
- The highest recorded value was 3,134 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Colombia?
- The lowest recorded value was 1,376 in 2020.
- How does Colombia rank for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 39th out of 155 countries with data for 2021.
- Where does this Colombia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).